Emily H Cheng

Title: Innovations of Emily H Cheng

Introduction

Emily H Cheng is a prominent inventor based in Englewood Cliffs, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of proliferative diseases. With a total of three patents to her name, her work focuses on developing novel compounds that can inhibit specific proteins associated with various diseases.

Latest Patents

One of her latest patents is titled "Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases." This patent describes phenylsulfonamido-benzofuran derivatives and their pharmaceutically acceptable salts. The patent also outlines pharmaceutical compositions, methods, uses, and kits involving these compounds for treating and preventing proliferative diseases, including cancers, inflammatory diseases, and autoimmune diseases. The compounds and pharmaceutical compositions inhibit at least one protein of the BCL-2 family, which plays a crucial role in the treatment and prevention of these diseases. Notably, some of the compounds are selective inhibitors of MCL-1, a member of the BCL-2 family.

Career Highlights

Emily has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and Albert Einstein College of Medicine. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Emily has collaborated with notable colleagues, including James Hsieh and Paul Jeng. Their combined expertise has further advanced the research and development of innovative treatments.

Conclusion

Emily H Cheng is a trailblazer in the field of medical innovation, with her patents paving the way for new treatments for proliferative diseases. Her work exemplifies the impact of dedicated research and collaboration in advancing healthcare solutions.